NuVasive Inc
NASDAQ:NUVA
NuVasive Inc
Depreciation & Amortization
NuVasive Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NuVasive Inc
NASDAQ:NUVA
|
Depreciation & Amortization
-$40.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
-$840m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
-$627m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-15%
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
-$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
-$3.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NuVasive Inc's Depreciation & Amortization?
Depreciation & Amortization
-40.5m
USD
Based on the financial report for Jun 30, 2023, NuVasive Inc's Depreciation & Amortization amounts to -40.5m USD.
What is NuVasive Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-10%
Over the last year, the Depreciation & Amortization growth was 26%. The average annual Depreciation & Amortization growth rates for NuVasive Inc have been 7% over the past three years , 4% over the past five years , and -10% over the past ten years .